These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 26540031)

  • 21. Small molecule inhibitors of the c-Jun N-terminal kinase (JNK) possess antiviral activity against highly pathogenic avian and human pandemic influenza A viruses.
    Nacken W; Ehrhardt C; Ludwig S
    Biol Chem; 2012 May; 393(6):525-34. PubMed ID: 22628315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel link of HLA locus to the regulation of immunity and infection: NFKBIL1 regulates alternative splicing of human immune-related genes and influenza virus M gene.
    An J; Nakajima T; Shibata H; Arimura T; Yasunami M; Kimura A
    J Autoimmun; 2013 Dec; 47():25-33. PubMed ID: 23953137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemical Genomics Approach Leads to the Identification of Hesperadin, an Aurora B Kinase Inhibitor, as a Broad-Spectrum Influenza Antiviral.
    Hu Y; Zhang J; Musharrafieh R; Hau R; Ma C; Wang J
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and synthesis of a library of lead-like 2,4-bisheterocyclic substituted thiophenes as selective Dyrk/Clk inhibitors.
    Schmitt C; Kail D; Mariano M; Empting M; Weber N; Paul T; Hartmann RW; Engel M
    PLoS One; 2014; 9(3):e87851. PubMed ID: 24676346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rational design of potent sialidase-based inhibitors of influenza virus replication.
    von Itzstein M; Wu WY; Kok GB; Pegg MS; Dyason JC; Jin B; Van Phan T; Smythe ML; White HF; Oliver SW
    Nature; 1993 Jun; 363(6428):418-23. PubMed ID: 8502295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, biological evaluation and molecular modelling studies of 4-anilinoquinazoline derivatives as protein kinase inhibitors.
    Waiker DK; Karthikeyan C; Poongavanam V; Kongsted J; Lozach O; Meijer L; Trivedi P
    Bioorg Med Chem; 2014 Mar; 22(6):1909-15. PubMed ID: 24530227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cappariloside A shows antiviral and better anti-inflammatory effects against influenza virus via regulating host IFN signaling, in vitro and vivo.
    Li Z; Zhao J; Zhou H; Li L; Ding Y; Li J; Zhou B; Jiang H; Zhong N; Hu W; Yang Z
    Life Sci; 2018 May; 200():115-125. PubMed ID: 29555588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological Evaluation of Uridine Derivatives of 2-Deoxy Sugars as Potential Antiviral Compounds against Influenza A Virus.
    Krol E; Wandzik I; Krejmer-Rabalska M; Szewczyk B
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28777309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging cellular targets for influenza antiviral agents.
    Müller KH; Kakkola L; Nagaraj AS; Cheltsov AV; Anastasina M; Kainov DE
    Trends Pharmacol Sci; 2012 Feb; 33(2):89-99. PubMed ID: 22196854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific CLK inhibitors from a novel chemotype for regulation of alternative splicing.
    Fedorov O; Huber K; Eisenreich A; Filippakopoulos P; King O; Bullock AN; Szklarczyk D; Jensen LJ; Fabbro D; Trappe J; Rauch U; Bracher F; Knapp S
    Chem Biol; 2011 Jan; 18(1):67-76. PubMed ID: 21276940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-influenza A virus activity of uridine derivatives of 2-deoxy sugars.
    Krol E; Wandzik I; Gromadzka B; Nidzworski D; Rychlowska M; Matlacz M; Tyborowska J; Szewczyk B
    Antiviral Res; 2013 Oct; 100(1):90-7. PubMed ID: 23911991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel small-molecule compound disrupts influenza A virus PB2 cap-binding and inhibits viral replication.
    Yuan S; Chu H; Zhang K; Ye J; Singh K; Kao RY; Chow BK; Zhou J; Zheng BJ
    J Antimicrob Chemother; 2016 Sep; 71(9):2489-97. PubMed ID: 27272726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discovery of 3,6-disubstutited-imidazo[1,2-a]pyridine derivatives as a new class of CLK1 inhibitors.
    Zhang Y; Xia A; Zhang S; Lin G; Liu J; Chen P; Mu B; Jiao Y; Xu W; Chen M; Li L
    Bioorg Med Chem Lett; 2021 Jun; 41():127881. PubMed ID: 33662541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro inhibition of influenza A virus infection by marine microalga-derived sulfated polysaccharide p-KG03.
    Kim M; Yim JH; Kim SY; Kim HS; Lee WG; Kim SJ; Kang PS; Lee CK
    Antiviral Res; 2012 Feb; 93(2):253-259. PubMed ID: 22197247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay.
    Adcock RS; Chu YK; Golden JE; Chung DH
    Antiviral Res; 2017 Feb; 138():47-56. PubMed ID: 27919709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Experimental study of Grippferon antiviral activity against Mexican pandemic influenza virus A/H1N1/2009 in vitro].
    Loginova SIa; Borisevich SV; Shchukina VN; Borisevich GV; Bondarev VP; Shevtsov VA
    Antibiot Khimioter; 2011; 56(5-6):7-10. PubMed ID: 22145225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic diversification of benzylidene heterocycles yields novel inhibitor scaffolds selective for Dyrk1A, Clk1 and CK2.
    Mariano M; Hartmann RW; Engel M
    Eur J Med Chem; 2016 Apr; 112():209-216. PubMed ID: 26896709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Viral M2 ion channel protein: a promising target for anti-influenza drug discovery.
    Moorthy NS; Poongavanam V; Pratheepa V
    Mini Rev Med Chem; 2014; 14(10):819-30. PubMed ID: 25342196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repurposing Kinase Inhibitors as Antiviral Agents to Control Influenza A Virus Replication.
    Perwitasari O; Yan X; O'Donnell J; Johnson S; Tripp RA
    Assay Drug Dev Technol; 2015 Dec; 13(10):638-49. PubMed ID: 26192013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effects of quercetin 3-rhamnoside on influenza A virus replication.
    Choi HJ; Song JH; Park KS; Kwon DH
    Eur J Pharm Sci; 2009 Jun; 37(3-4):329-33. PubMed ID: 19491023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.